Completed PHASE3 INTERVENTIONAL 6-arm NCT00390039

Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery

Randomized, Double-Blind, Active- and Placebo-Controlled Study of Analgesic Efficacy and Safety of Repeated Dosing of MNS075 (Intranasal Morphine), IV Morphine, and Placebo in Acute Post-Operative Pain After Elective Orthopedic Surgery

Sponsor: Javelin Pharmaceuticals

Conditions Pain, Postoperative

Interventions IV morphine Intranasal Morphine Intranasal morphine Placebo

Updated 6 times since 2017 Last updated: Jan 11, 2008 Started: May 31, 2006 Primary completion: Sep 30, 2006 Completion: Sep 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Pain, Postoperative and is currently completed. Javelin Pharmaceuticals leads this study, which shows 6 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Javelin Pharmaceuticals

Data source: Javelin Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery

Status Flow

Change History

Eligibility Summary

Contact Information

Study Locations

Related Trials